Study Status: Available
Recruit Status: Available
Study Type: Expanded Access
Official Title: An Expanded Access Imaging of Neuroendocrine Tumors Using 68Ga-DOTA-TOC
Brief Summary: The goal of this clinical research study is to use 68GA-DOTATOC instead of the standard-of-care 111-In-pentetreotide as a tracer chemical during PET/CT scans for diagnosing neuroendocrine tumors. A tracer is injected into participant's bloodstream to help the study doctor see possible tumors.